Filtered By:
Condition: Anaphylactic Shock

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 69 results found since Jan 2013.

A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive
ConclusionsThe most common adverse effects of levonorgestrel were not serious. This systematic review shows that data regarding the adverse reactions of repeated use of levonorgestrel are scarce. Studies on the multiple uses of levonorgestrel emergency contraception are still required to ensure its safety.
Source: Clinical Drug Investigation - March 10, 2020 Category: Drugs & Pharmacology Source Type: research

Qing-Kai-Ling Injection Induces Immediate Hypersensitivity Reaction via the Activation of Anaphylatoxin C3
Conclusion: QKLI-IHR is complement activation-related pseudoallergy, rather than an IgE-mediated allergy. QKLI activates C3 and might consequently provoke mast cells to release histamine, which is a principal effector of its IHR. The pseudoallergic reaction induced by QKLI was attributed to the extract of Isatidis Radix. This study suggests a potential therapeutic strategy for the prophylaxis and treatment of QKLI-IHR.
Source: Frontiers in Pharmacology - January 8, 2020 Category: Drugs & Pharmacology Source Type: research

Anaphylaxis-induced atrial fibrillation and anesthesia: Pathophysiologic and therapeutic considerations.
Abstract Atrial fibrillation is the most common cardiac arrhythmia in western society affecting more than 35 million individuals worldwide annually. It is a common postoperative complication and may also occur spontaneously during general and local anesthesia administration. Aging, diabetes mellitus, hypertension, and cardiovascular diseases including cardiomyopathies, congenital cardiac anomalies, heart failure, myocardial ischemia, pericarditis, previous cardiac surgery, vascular disease, and valvular heart disease are some correlated factors. Beyond age, increased incidence of atrial fibrillation has been corre...
Source: Annals of Cardiac Anaesthesia - December 31, 2019 Category: Anesthesiology Authors: Kounis NG, Koniari I, Tzanis G, Soufras GD, Velissaris D, Hahalis G Tags: Ann Card Anaesth Source Type: research

Hypersensitivity reactions to recombinant tissue plasminogen activator.
Abstract Recombinant tissue plasminogen activator (rtPA) is currently the only approved thrombolytic agent for treating acute ischaemic stroke that is widely used in clinical practice. However, it may cause haemorrhage and hypersensitivity reactions. Orolingual angioedema is an infrequent, usually mild but potentially life threatening, hypersensitivity reaction to rtPA. Our understanding of the basic biology of angioedema has increased in recent years. There is growing evidence that rtPA-induced orolingual angioedema is driven mainly by bradykinin generation rather than it being an anaphylactic response. Monitorin...
Source: Practical Neurology - July 3, 2019 Category: Neurology Authors: Alakbarzade V, O'Kane D, Pereira AC Tags: Pract Neurol Source Type: research

The Discovery and Development of Liraglutide and Semaglutide
We describe one such approach, albumin binding, and explain how it was applied in the development of the human GLP-1 analog liraglutide once daily and, subsequently, semaglutide once weekly. The pharmacology of these two long-acting GLP-1 analogs, in terms of improving glycemic control, reducing body weight and decreasing cardiovascular (CV) risk, is also reviewed, together with some novel biology. In addition, we describe the importance of accurate target (GLP-1 receptor) tissue expression analysis. Now an established class of agents, GLP-1-based therapies represent a significant advance in the treatment of T2D. All curr...
Source: Frontiers in Endocrinology - April 11, 2019 Category: Endocrinology Source Type: research

New Partnership Forms to Develop Breakthrough Neuromodulation Device
WeHealth, an e-health department of Servier Group, said it is in a partnership with Pathmaker Neurosystems, a pioneering clinical-stage bioelectronic medicine company. The two companies revealed plans to develop and commercialize the first neuromodulation technology designed to treat muscle spasticity non-invasively. The new technology will be known as the MyoRegulator device. The new MyoRegulator PM-200 provides a non-invasive treatment option for patients suffering from muscle spasticity, a common condition found in many patients suffering from stroke, cerebral palsy, multiple sclerosis, spinal cord injury, and traumatic...
Source: MDDI - March 26, 2019 Category: Medical Devices Authors: Kristopher Sturgis Tags: Business Source Type: news

Gadolinium to the rescue for mechanical thrombectomy in acute ischemic stroke.
CONCLUSION: Gadolinium-based contrast agents could be effective alternatives for cerebral DSA in patients undergoing mechanical thrombectomy for AIS who have a history of anaphylactic reaction to ICs. PMID: 30567455 [PubMed - as supplied by publisher]
Source: Interventional Neuroradiology - December 22, 2018 Category: Radiology Tags: Interv Neuroradiol Source Type: research

To bee or not to bee: The potential efficacy and safety of bee venom acupuncture in humans.
Abstract Bee venom acupuncture is a form of acupuncture in which bee venom is applied to the tips of acupuncture needles, stingers are extracted from bees, or bees are held with an instrument exposing the stinger, and applied to acupoints on the skin. Bee venom is a complex substance consisting of multiple anti-inflammatory compounds such as melittin, adolapin, apamin. Other substances such as phospholipase A2 can be anti-inflammatory in low concentrations and pro-inflammatory in others. However, bee venom also contains proinflammatory substances, melittin, mast cell degranulation peptide 401, and histamine. Never...
Source: Toxicon - September 27, 2018 Category: Toxicology Authors: Cherniack EP, Govorushko S Tags: Toxicon Source Type: research

The streptokinase therapy complications and its associated risk factors in patients with acute ...
Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Despite the progress in the treatment of AMI, streptokinase is still being used in many countries. Because of the critical condition of patients with AMI and complications of streptokinase therapy, this study was performed to evaluate the pattern of adverse drug reaction (ADRs) induced by streptokinase and its associated risk factors in patients with acute ST elevation MI. A prospective cross-sectional study in a 14-month period was done at the university affiliated referral cardiovascular center. The Naranjo probability scale a...
Source: Iranian Journal of Pharmaceutical Research - February 28, 2018 Category: Drugs & Pharmacology Source Type: research

Antibiotic therapy for preventing infections in people with acute stroke.
CONCLUSIONS: Preventive antibiotics had no effect on functional outcome or mortality, but significantly reduced the risk of 'overall' infections. This reduction was driven mainly by prevention of urinary tract infection; no effect for pneumonia was found. PMID: 29355906 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - January 22, 2018 Category: General Medicine Authors: Vermeij JD, Westendorp WF, Dippel DW, van de Beek D, Nederkoorn PJ Tags: Cochrane Database Syst Rev Source Type: research

The streptokinase therapy complications and its associated risk factors in patients with acute ...
Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Despite the progress in the treatment of AMI, streptokinase is still being used in many countries. Because of the critical condition of patients with AMI and complications of streptokinase therapy, this study was performed to evaluate the pattern of adverse drug reaction (ADRs) induced by streptokinase and its associated risk factors in patients with acute ST elevation MI. A prospective cross-sectional study in a 14-month period was done at the university affiliated referral cardiovascular center. The Naranjo probability scale a...
Source: Iranian Journal of Pharmaceutical Research - December 31, 2017 Category: Drugs & Pharmacology Source Type: research

Thrombolysis of a stroke patient with history of rtPA-associated angioedema
We report such a case where a patient with previous rtPA-related orolingual angioedema was successfully treated with IV rtPA without adverse reactions.
Source: Neurology Clinical Practice - December 11, 2017 Category: Neurology Authors: De Los Rios La Rosa, F., Starosciak, A. K., Wolf, B. Tags: All Cerebrovascular disease/Stroke, Patient safety Case Source Type: research

The technique of superselective ophthalmic artery chemotherapy for retinoblastoma: The Garrahan Hospital experience.
Conclusion SOAC is a safe technique with a very low complication rate. PMID: 29119878 [PubMed - as supplied by publisher]
Source: Interventional Neuroradiology - November 10, 2017 Category: Radiology Tags: Interv Neuroradiol Source Type: research

Sodium Tetradecyl Sulfate: A Review of Clinical Uses
CONCLUSION: Although not always the most effective method of treatment in off-label usage, use of STS has been frequently selected for a variety of applications for reasons of simplicity, low cost, lack of availability of technologically advanced equipment, and intricacies related to anatomic location.
Source: Dermatologic Surgery - October 28, 2017 Category: Dermatology Tags: Review Article Source Type: research

Is Epinephrine Safe for Older Patients with Anaphylaxis?
This study aimed to determine the clinical value, and potential cardiovascular harm, on elderly patients with anaphylaxis who received intramuscular (IM) and IV epinephrine. Over a five-year period, the researchers examined the ED record of anaphylactic patients over the age of 50 who were transported to two urban EDs. They compared the clinical outcome and cardiovascular complications between younger and older adults who received epinephrine for anaphylaxis. Of the 2,995 patients with allergy-related complaints, 492 were treated for anaphylaxis. Of them, 122 (24.8%) were older adults. Only 36.1% of the older patients rece...
Source: JEMS Patient Care - June 1, 2017 Category: Emergency Medicine Authors: Keith Wesley, MD, FACEP Tags: Patient Care Columns Source Type: news